A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma.

NCT01237236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor
Lymphomas

Interventions

DRUG: LEE011

Sponsor

Novartis Pharmaceuticals